Structure of ACY-738
CAS No.: 1375465-91-0
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
ACY-738 inhibits HDAC6 with IC50 value of 1.7 nM.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1375465-91-0 |
Formula : | C14H14N4O2 |
M.W : | 270.29 |
SMILES Code : | O=C(C1=CN=C(NC2(C3=CC=CC=C3)CC2)N=C1)NO |
MDL No. : | MFCD28347706 |
InChI Key : | LIIWIMDSZVNYHY-UHFFFAOYSA-N |
Pubchem ID : | 57381425 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
N2a cells | 3μM | ACY-738 significantly increased acetylation levels of α-tubulin and histone 3 | PMC6612190 | |
RN46A-B14 cells | 2.5μM | 1 hour | To test the effect of ACY-738 on GR nuclear translocation, results showed that ACY-738 significantly inhibited DEX-induced GR translocation. | PMC4297530 |
RN46A-B14 cells | 2.5 μM | 4 hours | To evaluate the effect of ACY-738 on α-tubulin acetylation. Results showed that ACY-738 significantly increased the acetylation of α-tubulin but had no significant effect on histone H3K9 acetylation. | PMC3870780 |
Motor neurons | 1 µM | overnight | ACY-738, an HDAC6 inhibitor, was used to rescue axonal transport defects in FUS-ALS patient-derived motor neurons. Results showed that ACY-738 treatment significantly increased the number of moving mitochondria and ER vesicles in motor neurons, restoring axonal transport function. | PMC5636840 |
Mec2 cells | 1 μM | 24 hours | ACY738 treatment significantly delayed growth kinetics, reduced cell-cycle progression, and arrested cells in G1 phase, increasing apoptosis. | PMC6234358 |
OSU-CLL cells | 1 μM | 24 hours | ACY738 treatment significantly delayed growth kinetics, reduced cell-cycle progression, and arrested cells in G1 phase, increasing apoptosis. | PMC6234358 |
B cells and T cells | 4 μM | 24 hours | ACY-738 treatment significantly decreased CO2 production from glucose oxidation in B cells and reduced CO2 production from fatty acid oxidation in both T cells and B cells. | PMC6823248 |
HCT-116 cells | 800 nM | ACY-738 induces tubulin acetylation (a marker of HDAC6 inhibition) at 800nM, whereas histone acetylation (a marker of Class 1 HDAC inhibition) at that concentration is minimal. | PMC6823248 | |
Em-TCL1 B cells | 0.5μM | 24 hours | To assess the effect of HDAC6 inhibition on antigen presentation by CLL B cells, results showed that ACY738 pre-treatment dose-dependently enhanced T-cell activation. | PMC7719839 |
CLL patient B cells | 0.5μM | 24 hours | To assess the effect of HDAC6 inhibition on surface markers of CLL patient B cells, results showed increased expression of MHCII and MHCI, and decreased expression of PD-L1. | PMC7719839 |
OSU-CLL cells | 0.5μM | 24 hours | To evaluate the effect of HDAC6 inhibition on CLL B cell engagement with T cells, results showed increased expression of MHCI, MHCII, and CD86, and decreased expression of PD-L1 and 41BB-L. | PMC7719839 |
Mouse neuroblastoma (N2a) cells | 1 μM | overnight | To assess the effect of ACY-738 on α-tubulin acetylation, results showed that ACY-738 significantly enhanced the acetylation of α-tubulin without affecting histone acetylation. | PMC5398982 |
Mouse mesangial cells (MES 13) | 0.5, 1 or 5 nM | 2 hours pretreatment followed by 24 hours stimulation | ACY-738 treatment increased Hsp90 acetylation, decreased iNOS protein, and reduced NF-κB nuclear translocation. | PMC4666739 |
Mouse mesangial cells (MES 13) | 1, 2, 5, 10 or 100 nM | 24 hours | ACY-738 at 5 nM significantly increased α-tubulin acetylation with little to no effect on histone H3 acetylation. | PMC4666739 |
Dorsal root ganglion (DRG) neurons | 2.5 μM | overnight | To evaluate the ability of ACY-738 to restore mitochondrial axonal transport defects, results showed that ACY-738 significantly increased mitochondrial motility and total number. | PMC5398982 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | Chronic social defeat stress model | Intraperitoneal injection | 5 mg/kg | Once daily for 20 days | To test the resilience-promoting effect of ACY-738 in social defeat stress, results showed that ACY-738-treated mice maintained higher interaction ratios, indicating enhanced resilience to stress. | PMC4297530 |
Mice | NIH Swiss mice and HDAC6 KO mice on C57BL/6J background | Intraperitoneal injection | 5 mg/kg and 50 mg/kg | Single or repeated administration (24 h, 4 h, and 30 min before killing) | To evaluate the effect of ACY-738 on α-tubulin acetylation in the brain and its antidepressant-like behavioral effects. Results showed that ACY-738 significantly increased α-tubulin acetylation in the brain and exhibited antidepressant-like effects in the tail suspension test and social defeat paradigm. These effects were fully abrogated in mice with a neural-specific loss of function of HDAC6. | PMC3870780 |
Mice | EuTCL1 transgenic mouse model | Oral | 25 mg/kg/day | Once daily for 3 months | ACY738 treatment significantly prolonged overall survival, reduced tumor burden and splenomegaly, decreased proliferation of malignant B cells, and increased sensitivity to apoptosis. | PMC6234358 |
NZB/W F1 mice | Systemic lupus erythematosus model | Dietary administration | 200 mg/kg | Daily administration for 4 weeks | ACY-738 treatment significantly reduced manifestations of lupus nephritis in NZB/W mice, decreased IgG and C3 deposition in glomeruli, and reduced plasma cell and germinal center formation in the spleen. | PMC6823248 |
Mice | TgFUS+/+ mouse model | Oral | 100 mg/kg | Daily administration starting at symptom onset (P30) | ACY-738 treatment significantly extended the lifespan of TgFUS+/+ mice, improved motor performance, and reduced weight loss | PMC6612190 |
Mice | Em-TCL1 adoptive transfer model | Oral | 25mg/kg/day | Once daily for 2 weeks | To evaluate the effect of HDAC6 inhibition on CLL progression, results showed that ACY738 delayed CLL progression, reduced PD-L1 expression, and lowered IL-10 levels. | PMC7719839 |
Mice | Mutant HSPB1-induced CMT2 mouse model | Intraperitoneal injection | 3 mg/kg | Once daily for 21 days | To assess the ability of ACY-738 to reverse motor and sensory deficits, results showed that ACY-738 significantly improved action potential amplitudes in motor and sensory nerves and increased reinnervation of neuromuscular junctions. | PMC5398982 |
Mice | Amyloid precursor protein/presenilin 1 (APP/PS1) mouse model | Oral | 100 mg/kg | Daily for 21 days or 90 days | To evaluate the effects of ACY-738 on axonal transport, behavior, and pathology. Results showed that ACY-738 treatment significantly improved axonal transport rates, recovered short-term learning and memory deficits, reduced hyperactivity, and modified tau and tubulin. | PMC5975056 |
Mice | Transgenic FUS mice (FUS+/+) expressing wild-type human FUS under the control of the mouse prion promoter (PrP) | Oral | 100 mg/kg | Daily administration starting at symptom onset (30 days) until 60 days | ACY-738 treatment restored histone acetylation, slowed down disease progression and significantly expanded the lifespan of transgenic FUS mice. Additionally, ACY-738 restored metabolic alterations in the spinal cord, specifically targeting glycerophospholipid metabolism and reducing cholesteryl esters accumulation. | PMC8541517 |
Tags: ACY-738 | ACY738 | ACY 738 | HDAC | Histone deacetylases | HDAC6 inhibitor | HDAC1 inhibitor | HDAC2 inhibitor | HDAC3 inhibitor | 1375465-91-0
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL